The report includes the following:
- Industry analysis including market value, market volume, market share and forecast growth till 2013
- Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
- SWOT and 5-year financial analysis of top 10 players in the industry
- Descriptive profiles of the leading players including the strategic initiatives undertaken in the last 12 months
The top 10 companies have been ascertained based on their global revenues for the year ended December 2008.
Highlights:
The global pharmaceuticals industry generated total revenues of $615.1 billion in 2008, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2004-08. The industry's total revenues are expected to touch $734 billion by the end of 2013, representing a CAGR of 3.6% for the 2008-13 period.
The top 10 global pharmaceutical companies recorded revenues of $348.3 billion during 2008, an increase of 4% over 2007. The operating profit of these companies was $81.6 billion during 2008, an increase of 11.6% over 2007. The net profit was $65.1 billion in 2008, an increase of 12.1% over 2007.
The average operating margin of the top 10 companies was 23.3% in 2008 as compared to 23.1% in 2007. The net margin was 20.2% in 2008 as compared with 19.3% in 2007.
Since 2004, the global pharmaceuticals market has witnessed moderate growth across different geographies. The market growth is expected to decelerate through to 2013 due to increased number of patent expiries and intensifying competition from generics.
Reasons to Purchase
- Gain insights into the industry, leading companies and competitors through a single report
- Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data
- Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies
- Determine industry attractiveness from five-forces analysis of constituent segments
目录
- Executive Summary
- Industry analysis
- Industry definition
- Research highlights
- Top 10 companies landscape
- Market value
- Market forecast
- Market segmentation—product
- Market segmentation—geographic
- Five Forces Analysis
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
- Top 10 Companies Landscape
- Overview
- Revenue analysis
- Financial performance analysis
- Company Reports
- Pfizer Inc
- GlaxoSmithKline Plc
- F. Hoffmann-La Roche
- Novartis
- Sanofi-Aventis
- AstraZeneca
- Abbott Laboratories
- Merck & Co., Inc.
- Wyeth
- Bristol-Myers Squibb Company
- Five Year Financial Information
- Pfizer
- GlaxoSmithKline
- F. Hoffman-La Roche
- Novartis
- Sanofi-Aventis
- AstraZeneca
- Abbott Laboratories
- Merck & Co.
- Wyeth
- Bristol-Myers Squibb Company
- APPENDIX
- FIGURES
- Figure 1: Global pharmaceuticals market, $ billion, 2004-2008
- Figure 2: Global pharmaceuticals market forecast, $ billion, 2008-2013
- Figure 3: Global pharmaceuticals market segmentation—product, % share 2008*
- Figure 4: Global pharmaceuticals market segmentation—geography, % share 2008*
- Figure 5: Forces driving competition in the global pharmaceuticals market
- Figure 6: Drivers of buyer power in the global pharmaceuticals market
- Figure 7: Drivers of supplier power in the global pharmaceuticals market
- Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market
- Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market
- Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market
- Figure 11: Revenues of global top 10 pharmaceutical companies, $ million, FY2008
- Figure 12: Revenue growth of global top 10 pharmaceutical companies, 2006-2008
- Figure 13: Operating performance analysis, FY2008
- Figure 14: Net profit analysis, FY2008
- TABLES
- Table 1: Global pharmaceutical market, $ billion, 2004-2008
- Table 2: Global pharmaceuticals market forecast, $ billion, 2008-2013
- Table 3: Global pharmaceuticals market segmentation—product , % share 2008*
- Table 4: Global pharmaceuticals market segmentation—geography, % share 2008*
- Table 5: Revenues of global top 10 pharmaceutical companies, $ million, FY2008
- Table 6: Revenue growth of global top 10 pharmaceutical companies, 2006-2008
- Table 7: Key financials of global top 10 pharmaceutical companies, FY2008
- Table 8: Key industry specific ratios-FY2008
- Table 9: Pfizer—Financial and operational highlights, 2004-2008 ($ million)
- Table 10: Pfizer—Key industry specific ratios, 2004-2008
- Table 11: GlaxoSmithKline—Financial and operational highlights, 2004-2008 ($ million)
- Table 12: GlaxoSmithKline—Key industry specific ratios, 2004-2008
- Table 13: F. Hoffman-La Roche—Financial and operational highlights, 2004-2008 ($ million)
- Table 14: F. Hoffman-La Roche—Key industry specific ratios, 2004-2008
- Table 15: Novartis—Financial and operational highlights, 2004-2008 ($ million)
- Table 16: Novartis—Key industry specific ratios, 2004-2008
- Table 17: Sanofi-Aventis—Financial and operational highlights, 2004-2008 ($ million)
- Table 18: Sanofi-Aventis—Key industry specific ratios, 2004-2008
- Table 19: AstraZeneca—Financial and operational highlights, 2004-2008 ($ million)
- Table 20: AstraZeneca—Key industry specific ratios, 2004-2008
- Table 21: Abbott Laboratories—Financial and operational highlights, 2004-2008 ($ million)
- Table 22: Abbott Laboratories—Key industry specific ratios, 2004-2008
- Table 23: Merck & Co.—Financial and operational highlights, 2004-2008 ($ million)
- Table 24: Merck & Co.—Key industry specific ratios, 2004-2008
- Table 25: Wyeth—Financial and operational highlights, 2004-2008 ($ million)
- Table 26: Wyeth—Key industry specific ratios, 2004-2008
- Table 27: Bristol-Myers Squibb Company—Financial and operational highlights, 2004-2008 ($ million)
- Table 28: Bristol-Myers Squibb Company—Key industry specific ratios, 2004-2008
